What is Alverine?

Category: Prescription Drugs

Most popular types: Spasmonal


Alverine citrate is an antispasmodic medicine which is used to relieve abdominal muscle spasms. It is particularly useful to help ease the spasm-type pain that may be associated with irritable bowel syndrome and similar conditions. It can also be used to help relieve period pain cramps.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Irritable bowel syndrome 8 2
Bowel irritability 2 0
Bladder problems 1 0
Bowel problems 1 1
Crohn's disease 1 0
Dysmenorrhea 1 0

Show all 8 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 3

Commonly reported side effects and conditions associated with Alverine

Side effect Patients Percentage


Based on patients currently taking Alverine

Dosage Patients Percentage
1 capsule(s) three times daily 1

Why patients stopped taking Alverine

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 1
Other 1
Personal research 1
See all 3 patients who've stopped taking Alverine


Currently taking Alverine

Duration Patients Percentage
2 - 5 years 1

Stopped taking Alverine

Duration Patients Percentage
1 - 2 years 2
2 - 5 years 1
Adherence Evaluations Percentage
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 2

What people switch to and from

Patients started taking Alverine after stopping:

Treatment Patients Percentage
Mebeverine (Colofac) 1
Scopolamine (Buscopan) 1

Patients stopped taking Alverine and switched to:

Treatment Patients Percentage
Scopolamine (Buscopan) 2
Last updated:
There are no evaluations for Alverine.